Hautzel H - Search Results

1

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial.

Schuler M, Cuppens K, Plönes T, Wiesweg M, Du Pont B, Hegedus B, Köster J, Mairinger F, Darwiche K, Paschen A, Maes B, Vanbockrijck M, Lähnemann D, Zhao F, Hautzel H, Theegarten D, Hartemink K, Reis H, Baas P, Schramm A, Aigner C. Schuler M, et al. Among authors: hautzel h. Nat Med. 2024 Jun;30(6):1602-1611. doi: 10.1038/s41591-024-02965-0. Epub 2024 Apr 30. Nat Med. 2024. PMID: 38689060 Free PMC article. Clinical Trial.

2

Differential modulation of valence and arousal in high-alexithymic and low-alexithymic individuals.

Heinzel A, Schäfer R, Müller HW, Schieffer A, Ingenhag A, Northoff G, Franz M, Hautzel H. Heinzel A, et al. Among authors: hautzel h. Neuroreport. 2010 Oct 27;21(15):998-1002. doi: 10.1097/WNR.0b013e32833f38e0. Neuroreport. 2010. PMID: 20811301

3

GABAergic and glutamatergic effects on nigrostriatal and mesolimbic dopamine release in the rat.

Nikolaus S, Beu M, Wittsack HJ, Müller-Lutz A, Antke C, Hautzel H, Mori Y, Mamlins E, Antoch G, Müller HW. Nikolaus S, et al. Among authors: hautzel h. Rev Neurosci. 2020 Aug 27;31(6):569-588. doi: 10.1515/revneuro-2019-0112. Rev Neurosci. 2020. PMID: 32619197 Free article. Review.

4

Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas?

Pauleit D, Langen KJ, Floeth F, Hautzel H, Riemenschneider MJ, Reifenberger G, Shah NJ, Müller HW. Pauleit D, et al. Among authors: hautzel h. J Magn Reson Imaging. 2004 Nov;20(5):758-64. doi: 10.1002/jmri.20177. J Magn Reson Imaging. 2004. PMID: 15503327 Clinical Trial.

5

FDG-PET Response Prediction in Pediatric Hodgkin's Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value.

Hussien AE, Furth C, Schönberger S, Hundsdoerfer P, Steffen IG, Amthauer H, Müller HW, Hautzel H. Hussien AE, et al. Among authors: hautzel h. Cancers (Basel). 2015 Jan 28;7(1):287-304. doi: 10.3390/cancers7010287. Cancers (Basel). 2015. PMID: 25635760 Free PMC article.

6

Integration of Bronchoscopic Transesophageal Ultrasound Examination of the Left Adrenal Gland into Routine Lung Cancer Staging Workup: A Prospective Trial.

Darwiche K, Becker J, Winantea J, Karpf-Wissel R, Funke F, Stenzel E, Hautzel H, Hager T, Eisenmann S. Darwiche K, et al. Among authors: hautzel h. Respiration. 2020;99(1):43-49. doi: 10.1159/000503396. Epub 2019 Oct 16. Respiration. 2020. PMID: 31618731

7

Impact of EBUS-TBNA in addition to [¹⁸F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC.

Guberina M, Darwiche K, Hautzel H, Ploenes T, Pöttgen C, Guberina N, Herrmann K, Umutlu L, Wetter A, Theegarten D, Aigner C, Eberhardt WEE, Schuler M, Karpf-Wissel R, Stuschke M. Guberina M, et al. Among authors: hautzel h. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2894-2903. doi: 10.1007/s00259-021-05204-7. Epub 2021 Feb 5. Eur J Nucl Med Mol Imaging. 2021. PMID: 33547554 Free PMC article.

8

Preoperative chest computed tomography evaluation for predicting intraoperative lung resection strongly depends on interpreters experience.

Collaud S, Alnajdawi Y, Stork T, Plönes T, Stefani D, Tokuishi K, Valdivia D, Zaatar M, Hegedüs B, Umutlu L, Hautzel H, Aigner C. Collaud S, et al. Among authors: hautzel h. Lung Cancer. 2021 Apr;154:23-28. doi: 10.1016/j.lungcan.2021.02.004. Epub 2021 Feb 18. Lung Cancer. 2021. PMID: 33611223

9

Insights into immunometabolism: A dataset correlating the ¹⁸FDG PET/CT maximum standard uptake value of the primary tumor with the CCL18 serum level in non-small cell lung cancer.

Dönmez T, Höhne K, Zissel G, Herrmann K, Hautzel H, Aigner C, Hegedüs B, Ploenes T. Dönmez T, et al. Among authors: hautzel h. Data Brief. 2021 Feb 18;35:106859. doi: 10.1016/j.dib.2021.106859. eCollection 2021 Apr. Data Brief. 2021. PMID: 33665255 Free PMC article.

10

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

Guberina M, Poettgen C, Metzenmacher M, Wiesweg M, Schuler M, Aigner C, Ploenes T, Umutlu L, Gauler T, Darwiche K, Stamatis G, Theegarten D, Hautzel H, Jentzen W, Guberina N, Herrmann K, Eberhardt WEE, Stuschke M. Guberina M, et al. Among authors: hautzel h. J Nucl Med. 2021 May 20;62(12):1684-91. doi: 10.2967/jnumed.120.260646. Online ahead of print. J Nucl Med. 2021. PMID: 34016730 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters